U. Hadding

4.9k total citations
147 papers, 3.9k citations indexed

About

U. Hadding is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, U. Hadding has authored 147 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Immunology, 30 papers in Hematology and 29 papers in Molecular Biology. Recurrent topics in U. Hadding's work include Complement system in diseases (45 papers), Blood groups and transfusion (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). U. Hadding is often cited by papers focused on Complement system in diseases (45 papers), Blood groups and transfusion (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). U. Hadding collaborates with scholars based in Germany, Switzerland and Netherlands. U. Hadding's co-authors include D Bitter-Suermann, Walter Däubener, Hans Fischer, Hans‐Peter Hartung, Volker Brade, Birgit Henrich, Reinhard Bürger, Colin R. MacKenzie, Hans J. Müller‐Eberhard and Hans‐Peter Heinz and has published in prestigious journals such as Science, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

U. Hadding

142 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Hadding Germany 38 1.6k 1.1k 617 607 478 147 3.9k
Berish Y. Rubin United States 36 3.4k 2.1× 1.7k 1.6× 771 1.2× 1.6k 2.6× 410 0.9× 83 7.0k
William P. Lafuse United States 35 1.2k 0.8× 979 0.9× 591 1.0× 658 1.1× 473 1.0× 98 3.6k
S. E. Mergenhagen United States 37 1.9k 1.2× 1.0k 0.9× 268 0.4× 452 0.7× 314 0.7× 79 4.4k
Shawn J. Green United States 28 1.4k 0.9× 1.4k 1.4× 367 0.6× 842 1.4× 232 0.5× 47 4.6k
Heinrich Körner Australia 47 4.2k 2.6× 1.7k 1.6× 850 1.4× 1.2k 1.9× 337 0.7× 128 7.8k
John G. Raynes United Kingdom 32 727 0.5× 1.2k 1.1× 286 0.5× 629 1.0× 230 0.5× 93 3.1k
Takashi Yokochi Japan 41 2.5k 1.6× 1.9k 1.8× 460 0.7× 827 1.4× 255 0.5× 295 6.3k
Tasuke Konno Japan 24 1.3k 0.8× 1.5k 1.4× 841 1.4× 544 0.9× 359 0.8× 128 4.4k
Steven B. Mizel United States 46 4.4k 2.7× 2.6k 2.5× 421 0.7× 908 1.5× 240 0.5× 76 7.9k
Bruce S. Zwilling United States 32 1.1k 0.7× 535 0.5× 552 0.9× 537 0.9× 438 0.9× 92 2.8k

Countries citing papers authored by U. Hadding

Since Specialization
Citations

This map shows the geographic impact of U. Hadding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Hadding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Hadding more than expected).

Fields of papers citing papers by U. Hadding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Hadding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Hadding. The network helps show where U. Hadding may publish in the future.

Co-authorship network of co-authors of U. Hadding

This figure shows the co-authorship network connecting the top 25 collaborators of U. Hadding. A scholar is included among the top collaborators of U. Hadding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Hadding. U. Hadding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitz, Franz‐Josef, Christof von Eiff, Ad C. Fluit, et al.. (1999). Staphylococcus aureus small colony variants: rate of selection and MIC values compared to wild-type strains, using ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin. Clinical Microbiology and Infection. 5(6). 376–378. 10 indexed citations
2.
Henrich, Birgit, et al.. (1998). Cloning and Expression of P60, a Conserved Surface-Localized Protein of Mycoplasma hominis, in Escherichia coli. Biological Chemistry. 379(8-9). 1143–1150. 3 indexed citations
3.
Schmitz, F.-J., Ad C. Fluit, B. Hofmann, et al.. (1998). The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 42(6). 807–810. 141 indexed citations
4.
MacKenzie, Colin R., U. Hadding, & Walter Däubener. (1998). Interferon‐γ‐Induced Activation of Indoleamine 2,3‐Dioxygenase in Cord Blood Monocyte‐Derived Macrophages Inhibits the Growth of Group B Streptococci. The Journal of Infectious Diseases. 178(3). 875–878. 77 indexed citations
5.
Fischer, Hans‐Georg, et al.. (1997). Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitology Research. 83(7). 637–641. 66 indexed citations
6.
Fischer, Hans‐Georg, et al.. (1997). Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. European Journal of Immunology. 27(6). 1539–1548. 92 indexed citations
7.
MacKenzie, Colin R., Birgit Henrich, & U. Hadding. (1996). Biovar-specific epitopes of the urease enzyme of Ureaplasma urealyticum. Journal of Medical Microbiology. 45(5). 366–371. 5 indexed citations
8.
Däubener, Walter, et al.. (1996). Anti‐parasitic effector mechanisms in human brain tumor cells: Role of interferon‐γ and tumor necrosis factor‐α. European Journal of Immunology. 26(2). 487–492. 75 indexed citations
9.
Däubener, Walter, et al.. (1996). Protamine Enhances the Activity of Human Recombinant Interferon-γ. Journal of Interferon & Cytokine Research. 16(7). 531–536. 4 indexed citations
10.
11.
Eder, Claudia, Hans Fischer, U. Hadding, & Uwe Heinemann. (1995). Properties of voltage-gated potassium currents of microglia differentiated with granulocyte/macrophage colony-stimulating factor. The Journal of Membrane Biology. 147(2). 137–46. 33 indexed citations
12.
Fischer, Hans, Claudia Eder, U. Hadding, & Uwe Heinemann. (1995). Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states. Neuroscience. 64(1). 183–191. 69 indexed citations
13.
14.
Heyll, A., C. Aul, Michael J. Thomas, et al.. (1991). Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates. Annals of Hematology. 63(6). 328–332. 12 indexed citations
15.
Lüneberg, Edeltraud, et al.. (1991). Sequence and expression in Escherichia coli of a Mycoplasma hominis gene encoding elongation factor Tu. Gene. 102(1). 123–127. 11 indexed citations
16.
Däubener, Walter, et al.. (1987). Suppressive effects of C3b on monocyte‐dependent T cell proliferation. European Journal of Immunology. 17(12). 1775–1779. 6 indexed citations
17.
Bürger, Reinhard, D Bitter-Suermann, Michael Loos, & U. Hadding. (1977). Insoluble polyanions as activators of both pathways of complement.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 33(6). 827–37. 15 indexed citations
18.
Bürger, Reinhard, et al.. (1977). Dual function of insoluble polyanions. Formation of C1 and C42 sites in addition to activation of the alternative pathway of complement.. PubMed. 12. 78–81. 1 indexed citations
19.
Bitter-Suermann, D, et al.. (1976). C5 Activation by Enzymes of the Alternative Pathway of the Complement System. The Reaction of a C3 Cleaving Cobra Factor-B-Enzyme (VF-B) with Guinea Pig C5. The Journal of Immunology. 116(6). 1728–1729. 4 indexed citations
20.
Dukor, P., G. Schumann, Roland H. Gisler, et al.. (1974). COMPLEMENT-DEPENDENT B-CELL ACTIVATION BY COBRA VENOM FACTOR AND OTHER MITOGENS?. The Journal of Experimental Medicine. 139(2). 337–354. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026